This round-up looks at the latest financial report from major dietary supplement and infant formula firms, namely The a2 Milk Company, Blackmores, McPherson’s, Meiji, and BYHEALTH.
The a2 Milk Company (a2MC) said it has seen strong sales of its infant milk formula in China via both mother-and-baby stores and domestic e-commerce channels.
Australia’s and New Zealand’s infant formula makers have been “encouraged” by the recent success of local brand Bubs’ entry into the US amid the shortage crisis in the country, with a number now examining export opportunities.
The a2 Milk Company (a2MC) has revealed its 1H22 results, which it said are in line with expectations, and place it in a strong position to execute its strategy and deliver revenue growth in FY22 in a challenging and volatile market.
Regional analysts are divided on The a2 Milk Company’s long-term growth potential, especially in China – its current largest market – amid acquisition rumours.
